Clear Search

Showing 2 results for “Targeted Therapies” published 2020 & later.

Efficacy and Safety of Combination Targeted Therapies in Immune-mediated Inflammatory Disease: The COMBIO Study

Dig Liver Dis. 2022 doi: 10.1016/j.dld.2022.07.012

This study suggested that COMBIO (combination of targeted therapy) appears to be effective in achieving significant and mild-to-moderate improvement in half and a quarter of patients with IMIDs, respectively. This was an ambispective study of a French cohort of patients from gastroenterology, rheumatology, and dermatology.

Read more…

Keywords:

Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study

Arthritis Res Ther. 2022 doi: 10.1186/s13075-022-02807-9

Retrospective, longitudinal, population-based study shows that despite an overall higher incidence of hospitalised infection (HI) in both elderly and older elderly patients compared to young patients, the risks of HI in patients exposed to targeted therapy versus MTX is not significantly increased.

Read more…